Herper, Matthew
January 2011
Forbes Asia;Jan2011, Vol. 7 Issue 1, p34
The article focuses on the gene decoder, Personal Genome Machine (PGM) invented by engineer and entrepreneur Jonathan Rothberg. It discusses different aspects of the machine which is a desktop decoder and is expected to initiate revolution in medicine, food, energy, even consumer products. The article also presents a chart depicting the companies that deal in DNA decoders which include Illumina, Oxford Nanopore Technologies Ltd., and Life Technologies Inc.


Related Articles

  • Oxford Nanopore, Illunima Seek Affordable Sequencing. Moran, Nuala // BioWorld International;1/14/2009, Vol. 14 Issue 2, p5 

    The article reports on the agreement signed by Oxford Nanopore Technologies Ltd. to commercialize its low-cost DNA sequencing technology with Illumina Inc., under which Illumina will exclusively market, sell, distribute, and service sequencers based on Oxford Nanopore's technology. Illumina also...

  • Life Technologies launches 400 bp sequencing kit.  // BioSpectrum;Jan2013, Vol. 11 Issue 1, p83 

    The article offers brief information on the 400 base-pair sequencing kit for the Ion PGM Sequencer from Life Technologies.

  • Sequence DNA in seconds. Graham-Rowe, Duncan // New Scientist;2/25/2012, Vol. 213 Issue 2853, p23 

    The article reports that the applied science company Oxford Nanopore Technologies has introduced the MinION DNA sequencing device, a portable computer memory stick-like product for the rapid analysis of simple genomes. Possible applications for the technology are explored, including cancer...

  • Genome deal seeks to accelerate pore sequencing.  // Nature;1/15/2009, Vol. 457 Issue 7227, p248 

    The article reports that the San Diego, California based biotechnology company Illumina purchased all rights to market, sell and distribute products based on the DNA sequencing technology belonging to Oxford Nanopore Technologies of Great Britain. This technique identifies sequences by passing...

  • Illumina takes a $18M stake in UK firm Oxford Nanopore.  // Medical Device Daily;1/13/2009, Vol. 13 Issue 7, p3 

    The article reports that Illumina in San Diego, California, and Oxford Nanopore Technologies in Oxford, England, has entered a strategic alliance. It states that the alliance includes a commercialization agreement and equity investment. It talks about the terms of the commercialization agreement...

  • Genomic Center Upgrade Creates Sales for Illumina. Chambers, Heather // San Diego Business Journal;6/14/2010, Vol. 31 Issue 24, p6 

    The article reports on the move of Illumina Inc. in San Diego, California to sell 51 of its latest generation genetic sequencing machines to genomic research center Broad Institution in Cambridge, Massachusetts.

  • How Many Planning to Join SHOP to Shop for Co. Health Plans? Keshavan, Meghana // San Diego Business Journal;11/25/2013, Vol. 34 Issue 47, p10 

    The article offers information on topics related to health care insurance industry in San Diego, California as of November 25, 2013. It discusses the Covered California's Small Business Health Options Program (SHOP) that is scheduled to go online on November 25. It mentions that the shares of...

  • Roche Abandons Hostile Takeover Bid for Illumina.  // MondayMorning;4/23/2012, Vol. 20 Issue 17, p1 

    The article discusses the rejection of F. Hoffmann-La Roche Ltd. of Switzerland for buyout of Illumina Inc. of California. It mentions that the investors of the company are concerned about the company's gene-mapping technology. It adds that Oxford Nanopore Technologies Ltd. in Great Britain and...

  • Third-generation sequencing fireworks at Marco Island. Munroe, David J.; Harris, Timothy J. R. // Nature Biotechnology;May2010, Vol. 28 Issue 5, p426 

    The article discusses advances in genetic sequencing platforms. It highlights the role of developments and innovations in driving DNA sequencing as the preeminent technology pushing future developments in genomics. It cites four third-generation sequencing platforms which are in various stages...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics